PMID- 27306411 OWN - NLM STAT- MEDLINE DCOM- 20161226 LR - 20220331 IS - 1744-8069 (Electronic) IS - 1744-8069 (Linking) VI - 12 DP - 2016 TI - EXPRESS: NGF-trkA signaling modulates the analgesic effects of prostatic acid phosphatase in resiniferatoxin-induced neuropathy. LID - 10.1177/1744806916656846 [doi] LID - 1744806916656846 AB - BACKGROUND: Neuropathic pain in small-fiber neuropathy results from injury to and sensitization of nociceptors. Functional prostatic acid phosphatase (PAP) acts as an analgesic effector. However, the mechanism responsible for the modulation of PAP neuropathology, which leads to loss of the analgesic effect after small-fiber neuropathy, remains unclear. RESULTS: We used a resiniferatoxin (RTX)-induced small-fiber neuropathy model to examine whether functional PAP(thorn) neurons are essential to maintain the analgesic effect. PAP(thorn) neurons were categorized into small to medium neurons (25th-75th percentile: 17.1-23.7 mm); these neurons were slightly reduced by RTX (p(1/4)0.0003). By contrast, RTX-induced activating transcription factor 3 (ATF3), an injury marker, in PAP(thorn) neurons (29.0%5.6% vs. 0.2%0.2%, p(1/4)0.0043), indicating PAP neuropathology. Moreover, the high-affinity nerve growth factor (NGF) receptor (trkA) colocalized with PAP and showed similar profiles after RTX-induced neuropathy, and the PAP/trkA ratios correlated with the degree of mechanical allodynia (r(1/4)0.62, p(1/4)0.0062). The NGF inducer 4-methylcatechol (4MC) normalized the analgesic effects of PAP; specifically, it reversed the PAP and trkA profiles and relieved mechanical allodynia. Administering 2.5S NGF showed similar results to those of administering 4MC. This finding suggests that the analgesic effect of functional PAP is mediated by NGF-trkA signaling, which was confirmed by NGF neutralization. CONCLUSIONS: This study revealed that functional PAP(thorn) neurons are essential for the analgesic effect, which is mediated by NGF-trkA signaling. FAU - Wu, Chieh-Hsin AU - Wu CH AD - Kaohsiung Medical University Chung Ho Memorial Hospital. FAU - Ho, Wan-Yi AU - Ho WY AD - Kaohsiung Medical University. FAU - Lee, Yi-Chen AU - Lee YC AD - Kaohsiung Medical University. FAU - Lin, Chih-Lung AU - Lin CL AD - Kaohsiung Medical University Hospital. FAU - Hsieh, Yu-Lin AU - Hsieh YL AD - Kaohsiung Medical University Chung Ho Memorial HospitalKaohsiung Medical UniversityKaohsiung Medical UniversityKaohsiung Medical University Hospital ylhsieh@kmu.edu.tw. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20160615 PL - United States TA - Mol Pain JT - Molecular pain JID - 101242662 RN - 0 (Analgesics) RN - 0 (Catechols) RN - 0 (Diterpenes) RN - 0 (Receptors, Purinergic P2X3) RN - 12GLI7JGB3 (4-methylcatechol) RN - 9061-61-4 (Nerve Growth Factor) RN - A5O6P1UL4I (resiniferatoxin) RN - EC 2.7.10.1 (Receptor, trkA) RN - EC 3.1.3.2 (Acid Phosphatase) RN - EC 3.1.3.2 (prostatic acid phosphatase) SB - IM MH - Acid Phosphatase/*metabolism MH - Analgesics/*metabolism MH - Animals MH - Catechols MH - Diterpenes MH - Hyperalgesia/metabolism MH - Mice MH - Models, Biological MH - Nerve Growth Factor/*metabolism MH - Neuralgia/*chemically induced/*metabolism MH - Neurons/metabolism/pathology MH - Phenotype MH - Receptor, trkA/*metabolism MH - Receptors, Purinergic P2X3/metabolism MH - *Signal Transduction PMC - PMC4956004 EDAT- 2016/06/17 06:00 MHDA- 2016/12/27 06:00 PMCR- 2016/06/15 CRDT- 2016/06/17 06:00 PHST- 2016/06/17 06:00 [entrez] PHST- 2016/06/17 06:00 [pubmed] PHST- 2016/12/27 06:00 [medline] PHST- 2016/06/15 00:00 [pmc-release] AID - 12/0/1744806916656846 [pii] AID - 10.1177_1744806916656846 [pii] AID - 10.1177/1744806916656846 [doi] PST - epublish SO - Mol Pain. 2016 Jun 15;12:1744806916656846. doi: 10.1177/1744806916656846. Print 2016.